The 45 rating InvestorsObserver gives to FibroGen Inc (FGEN) stock puts it near the bottom of the Biotechnology industry. In addition to scoring higher than 32 percent of stocks in the Biotechnology industry, FGEN’s 45 overall rating means the stock scores better than 45 percent of all stocks.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 45 means the stock is more attractive than 45 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With FibroGen Inc Stock Today?
FibroGen Inc (FGEN) stock is up 4.25% while the S&P 500 is down -0.08% as of 12:30 PM on Monday, Jun 22. FGEN is up $1.69 from the previous closing price of $39.78 on volume of 288,180 shares. Over the past year the S&P 500 has risen 5.09% while FGEN is down -4.75%. FGEN lost -$1.32 per share the over the last 12 months.
To see InvestorsObserver's Sentiment Score for FibroGen Inc click here.
